Search Within

Richard Charles Meagher

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (23)
  2. Journal Article (8)
Groups
  1. Bone Marrow Transplant (31)
  2. CTCR Scholars (31)
  3. Center for Hematologic Malignancies (31)
  4. Department of Medicine (31)
  5. Hematologic Malignancies, Division of (31)
  6. MSK Grad Students (31)

More Groups

People
  1. Sergio Giralt (31)
  2. Hugo Castro-Malaspina (29)
  3. Miguel-Angel Perales (28)
  4. Sean Devlin (26)
  5. Guenther Koehne (22)
  6. Scott Avecilla (22)

More People

Years
  1. 2018 (3)
  2. 2017 (8)
  3. 2016 (12)
  4. 2015 (1)
  5. 2014 (6)
  6. 2013 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (16)
  2. Blood (8)
  3. Bone Marrow Transplantation (6)
  4. Science Translational Medicine (1)
Publishers
  1. Elsevier Inc. (16)
  2. American Society of Hematology (8)
  3. Nature Publishing Group (6)
  4. American Association for the Advancement of Science (1)

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response
    Journal Article

    Barba, P.; Hilden, P.; Devlin, S. M.; Maloy, M.; Dierov, D.; Nieves, J.; Garrett, M. D.; Sogani, J.; Cho, C.; Barker, J. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Toxicities in older adult patients undergoing CD34+ selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M.; Nieves, J. L.; Devlin, S.; Avecilla, S. T.; Meagher, R.; Shaffer, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Acute toxicities in patients receiving ex-vivo CD34+ selected allogeneic stem cell transplantation for hematologic malignancies
    Meeting Abstract

    Herrera, D.; Perales, M. A.; Shah, G.; Scordo, M.; Devlin, S.; Maloy, M.; Nieves, J.; Avecilla, S.; Meagher, R.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Long-term prognosis of one-year survivors of CD34-selected allogeneic hematopoietic stem cell transplantation: A landmark analysis
    Meeting Abstract

    Cho, C.; Hsu, M.; Avecilla, S.; Barba, P.; Barker, J.; Castro-Malaspina, H.; Devlin, S.; Giralt, S.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Maloy, M.; Barker, J. N.; Castro-Malaspina, H.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save